Comparative Study of Subcutaneous Versus Intravenous IgG Replacement Therapy in Pediatric Patients with Primary Immunodeficiency Diseases: A Multicenter Study in Argentina

被引：0
|
作者：
Liliana Bezrodnik
Andrea Gómez Raccio
Gabriela Belardinelli
Lorena Regairaz
Damacia Díaz Ballve
Gisela Seminario
Ileana Moreira
Carlos Riganti
Claudio Cantisano
Héctor Díaz
Daniela Di Giovanni
机构：
[1] Inmunología,
[2] Hospital de Niños “Dr. Ricardo Gutiérrez”,undefined
[3] Inmunología,undefined
[4] Hospital de Niños “Sor María Ludovica”,undefined
[5] Inmunología,undefined
[6] Hospital de Niños Pedro Elizalde,undefined
[7] Inmunología,undefined
[8] Hospital de Niños “Dr. Ricardo Gutiérrez”,undefined
来源：
Journal of Clinical Immunology | 2013年 / 33卷
关键词：
Argentina; children; immunoglobulin therapy; intravenous; primary immunodeficiency; subcutaneous; Beriglobina P;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1216 / 1222
页数：6
相关论文
共 50 条
  • [31] Health-Related Quality of Life of Patients with Primary Immunodeficiency Switching from Intravenous IgG to a New 20% Subcutaneous IgG
    Gonzalez Quevedo, Teresa
    Mannhardt-Laakmann, Wilma
    Bernatowska, Ewa
    Serban, Margit
    Jolles, Stephen
    de Gracia, Javier
    Grimbacher, Bodo
    Wang, Ed
    Borte, Michael
    CLINICAL IMMUNOLOGY, 2010, 135 : S87 - S87
  • [32] A clinician’s guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases
    Kristin Epland
    Daniel Suez
    Kenneth Paris
    Allergy, Asthma & Clinical Immunology, 18
  • [33] A clinician's guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases
    Epland, Kristin
    Suez, Daniel
    Paris, Kenneth
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2022, 18 (01):
  • [34] Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency
    Wasserman, Richard L.
    Church, Joseph A.
    Peter, Hans H.
    Sleasman, John W.
    Melamed, Isaac
    Stein, Mark R.
    Bichler, Johann
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 37 (3-4) : 272 - 278
  • [35] SAFETY/TOLERABILITY OF HUMAN IMMUNE GLOBULIN SUBCUTANEOUS, 20% IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES
    Paris, K.
    Derfalvi, B.
    Hussain, I.
    Haddad, E.
    Dicso, F.
    Darter, A.
    Doralt, J.
    Engl, W.
    Mccoy, B.
    Yel, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S97 - S97
  • [36] Efficacy and Safety of IgPro20, a 20% Immunoglobulin for Subcutaneous Administration, in Patients with Primary Immunodeficiency Switching from Intravenous Replacement Therapy
    Jolles, Stephen
    Cristea, Victor
    Wahn, Volker
    Debre, Marianne
    Longhurst, Hilary
    Zenker, Othmar
    Peter, Hans-Hartmut
    Borte, Michael
    CLINICAL IMMUNOLOGY, 2010, 135 : S86 - S87
  • [37] Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies
    Canessa, Clementina
    Iacopelli, Jessica
    Pecoraro, Antonio
    Spadaro, Giuseppe
    Matucci, Andrea
    Milito, Cinzia
    Vultaggio, Alessandra
    Agostini, Carlo
    Cinetto, Francesco
    Danieli, Maria Giovanna
    Gambini, Simona
    Marasco, Carolina
    Trizzino, Antonino
    Vacca, Angelo
    De Mattia, Domenico
    Martire, Baldassarre
    Plebani, Alessandro
    Di Gioacchino, Mario
    Gatta, Alessia
    Finocchi, Andrea
    Licciardi, Francesco
    Martino, Silvana
    De Carli, Marco
    Moschese, Viviana
    Azzari, Chiara
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2017, 30 (01) : 73 - 82
  • [38] Comparison of Clinical Outcomes and Laboratory Measures in Patients with Common Variable Immunodeficiency on Subcutaneous Immunoglobulin Replacement Versus Intravenous Immunoglobulin Replacement
    Shah, Shaili N.
    Todoric, Krista
    Tarrant, Teresa K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB89 - AB89
  • [39] EXPERIENCE WITH SUBCUTANEOUS LOADING OF VIVAGLOBIN® OR HIZENTRA® IN PRIMARY IMMUNODEFICIENCY PATIENTS NAIVE TO IMMUNOGLOBULIN REPLACEMENT THERAPY
    Koterba, A.
    Farnan, K.
    Sierra, C.
    Eufrasio, D.
    Stein, M. R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A101 - A101
  • [40] Prospective study on CVID patients with adverse reactions to intravenous or subcutaneous IgG administration
    Quinti, Isabella
    Soresina, Annarosa
    Agostini, Carlo
    Spadaro, Giuseppe
    Matucci, Andrea
    Sfika, Ifigeneia
    Martini, Helene
    Borghese, Federica
    Guerra, Andrea
    Alessandra, Vultaggio
    Visentini, Marcella
    Plebani, Alessandro
    Fiorilli, Massimo
    JOURNAL OF CLINICAL IMMUNOLOGY, 2008, 28 (03) : 263 - 267
12345